Vivoryon Therapeutics Revenue

Biotechnology Research • Halle, Saxony-Anhalt, Germany • 11-20 Employees

Vivoryon Therapeutics revenue & valuation

Annual revenue	$1,711,100
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,500,000
Total funding	No funding

Key Contacts at Vivoryon Therapeutics

Alexei Ahrens

Director Finance

Katharina Fuchs

Clinical Program Director

Ulrich Heiser

Senior Director Medicinal Chemistry

Manuela Bader

Director Ir & Communication

Antje Meyer

Director Bioanalytics

Company overview

Headquarters	Weinbergweg 22, Halle (Saale), 06120, DE
Phone number	+49493455559900
Website	vivoryon.com
NAICS	541714
SIC	873
Founded	1997
Employees	11-20
Socials

Vivoryon Therapeutics Email Formats

Vivoryon Therapeutics uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@vivoryon.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@vivoryon.com	100%

About Vivoryon Therapeutics

Vivoryon is a clinical stage biotechnology company focused on developing innovative small molecule-based medicines for the treatment of inflammatory and fibrotic disorders of the kidney. Driven by its passion for ground-breaking science and innovation, the Company strives to improve patient outcomes by changing the course of severe diseases through modulating the activity and stability of pathologically relevant proteins. Vivoryon’s most advanced program, varoglutamstat, a proprietary, first-in-class orally available QPCT/L inhibitor, is being evaluated to treat diabetic kidney disease.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

C-Suite

Entry

Employees by Department

Vivoryon Therapeutics has 9 employees across 5 departments.

Departments

Number of employees

Funding Data

Vivoryon Therapeutics has never raised funding before.

Vivoryon Therapeutics Tech Stack

Discover the technologies and tools that power Vivoryon Therapeutics's digital infrastructure, from frameworks to analytics platforms.

jQuery UI

JavaScript libraries

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Yoast SEO

SEO

Lightbox

JavaScript libraries

FancyBox

JavaScript libraries

Skrollr

JavaScript libraries

wpBakery

Page builders

Frequently asked questions

Vivoryon Therapeutics is located in Halle, Saxony-Anhalt, DE.

You can reach Vivoryon Therapeutics at +49493455559900.

Vivoryon Therapeutics generates an estimated annual revenue of $1,711,100. This revenue figure reflects the company's market position and business performance in its industry.

Vivoryon Therapeutics has an estimated valuation of $5,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Vivoryon Therapeutics was founded in 1997, making it 29 years old. The company has established itself as a significant player in its industry over this time.

Vivoryon Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Vivoryon Therapeutics

Alexei Ahrens

Director Finance

Katharina Fuchs

Clinical Program Director

Ulrich Heiser

Senior Director Medicinal Chemistry

Manuela Bader

Director Ir & Communication

Antje Meyer

Director Bioanalytics

4.8